It is vital for sponsors to reduce the burden on the site if they also want to lessen the strain on patients, said Shantheri Pai, associate director clinical operations for oncology at Gilead while ...

Alphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal ...

A tent erected during the pandemic worked its way into being an integral part of Beyul Retreat Center’s business model, ...

Spanish infrastructure manager Adif is tendering a contract to prepare a section of its 1000mm-gauge network for testing ...

Biomedical concepts by CDISC are tailored to ensure data consistency, and link information throughout the data pipeline.

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

IN8bio is accelerating patient enrollment in the INB-100 program and expects to complete enrollment of the expansion cohort in 2025. The company's FDA discussions confirmed that relapse-free survival ...

General and Administration (G&A) expenses for the three months ended December 31, 2024 were $3.6 million USD, compared to $5.3 million USD for the same period in 2023. The decrease was primarily ...

The Hammer Museum at UCLA presents the first museum exhibition inspired by Alice Coltrane’s life and legacy, “Alice Coltrane, ...

The company made an upfront payment and will provide success-based milestones and royalties in exchange for global rights.

Exploratory outcome measures include health-related quality of life, overall survival, and biomarker assessments. A broad cross-section of geographically and socioeconomically diverse clinical sites ...